Outsourcing Outlook: Contract Services' Crystal Ball

BioPharm International, BioPharm International-02-01-2003, Volume 16, Issue 2

by Jim Miller, Bio/Pharmaceutical Outsourcing Report Developments in 2002 such as acquisitions, excess manufacturing capacity, and less funding for biotechnology will continue to affect the industry long into the new year.